Physician profile
Gary N Wright
NPI 1841212750
$6,032.65
in general payments reported to CMS, 2019-2025
13 companies · $1,325 in 2025
The $1,325 reported for 2025 was more than what 90% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $310 · 2020: $198 · 2021: $553 · 2022: $806 · 2023: $1,117 · 2024: $1,723 · 2025: $1,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,142 · Education: $23.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,142.36 |
| Education | $23.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,806.41 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Janssen Pharmaceuticals, INC | $950.56 | 2022-2024 | Xarelto |
| Novo Nordisk INC | $408.75 | 2023-2025 | Ozempic, Wegovy, Rybelsus |
| Merck Sharp & Dohme LLC | $216.24 | 2019 | |
| Lilly USA, LLC | $192.66 | 2023-2025 | Mounjaro, Zepbound, Emgality |
| Boehringer Ingelheim Pharmaceuticals, INC. | $168.63 | 2025 | Jardiance |
| Glaxosmithkline, LLC. | $140.44 | 2019-2025 | Trelegy Ellipta |
| Pfizer INC. | $46.37 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $28.16 | 2025 | Givlaari |
| Amgen INC. | $27.88 | 2019-2024 | Krystexxa |
| Horizon Therapeutics Plc | $17.20 | 2023 | Krystexxa |
| Genentech USA, INC. | $16.05 | 2020 | |
| Allergan, INC. | $13.30 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.